University of Texas at San Antonio College of Sciences

THE WILDER INSTITUTE ANNOUNCES DR. GRÁINNE MCCABE AS ITS INAUGURAL CHIEF CONSERVATION OFFICER

Retrieved on: 
Monday, June 5, 2023
Science, IUCN, University, Roger W. Jones Award for Executive Leadership, AB, Danny Howells, Doctor of Philosophy, Organization, University of Texas at San Antonio College of Sciences, Nature, Risk, International Union for Conservation of Nature, Master, United Kingdom, Conservation, Ecosystem, Wilder, Biodiversity, Hunting

CALGARY, AB, June 5, 2023 /CNW/ - Today, the Wilder Institute, a global authority on wildlife conservation, announced the appointment of Dr. Gráinne Michelle McCabe as its Chief Conservation Officer, a newly-created role on its executive team focused on global expansion.

Key Points: 
  • CALGARY, AB, June 5, 2023 /CNW/ - Today, the Wilder Institute, a global authority on wildlife conservation, announced the appointment of Dr. Gráinne Michelle McCabe as its Chief Conservation Officer, a newly-created role on its executive team focused on global expansion.
  • "We are thrilled to welcome Dr. McCabe to the Wilder Institute's executive team," said Dr. Clément Lanthier, President & Chief Executive Officer of the Wilder Institute.
  • "This role was created to help strategically guide the Wilder Institute through our ambitious expansion of conservation programs by 2030.
  • "I am honoured to join the team and proud to help the Wilder Institute continue to grow its global reach.

Horizon Therapeutics plc Makes Founding Gift to Support the University of Notre Dame’s Patient Advocacy Initiative

Retrieved on: 
Friday, September 16, 2022
Science, Biotechnology, Research, General Health, Health, University, Education, Clinical Trials, Autoimmunity, Courage, Rare, Faculty, John Solomon Rarey, Twitter, Center, Notre Dame College, LinkedIn, Degenerative disease, Industry, Notre Dame, Neglected tropical diseases, Tropical disease, Program, Patient, Horizon Therapeutics, Curriculum, Physician, Instagram, Student, College, Nasdaq, Diagnosis, Drug development, MSPA, Â, Research, University of Notre Dame, Inflammation, Awareness, University, University of Texas at San Antonio College of Sciences, Education, Disease, Pharmaceutical industry, Medicine, Science, Facebook

Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University of Notre Dames Patient Advocacy Initiative in the College of Science.

Key Points: 
  • Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University of Notre Dames Patient Advocacy Initiative in the College of Science.
  • Notre Dames Patient Advocacy Initiative is a novel approach to enable advanced training, outreach and research to better serve the rare disease community.
  • It is crucial that we support Notre Dames innovative Patient Advocacy Initiative to help train the next generation of patient advocates and serve a broader segment of the rare disease community.
  • This gift helps put the Notre Dame Patient Advocacy Initiative on a path to forming successful patient advocates.